New RA guideline emphasizes maximizing methotrexate and biologics, minimizing steroids

ATLANTA — The American College of Rheumatology (ACR) will preview its 2020 Guideline for the Management of Rheumatoid Arthritis (RA) at ACR Convergence, the ACR’s annual meeting. The comprehensive, clinical recommendations for pharmacologic treatment of RA includes important updates to the previous guideline released in 2015. Rheumatoid arthritis (RA) is the most common type of…

Why a “board-certified cosmetic surgeon” isn’t a plastic surgeon, and what that means for you

November 6, 2020 – Cosmetic surgery is not just another way of saying plastic surgery. Doctors who advertise themselves as certified by the American Board of Cosmetic Surgery (ABCS) don’t measure up to meet the criteria required for board-certified plastic surgeons. In a study published in the November issue of Plastic and Reconstructive Surgery®, the…

Get on the grid: ‘Micro-doses’ of Botox provide up-close improvement of facial skin

November 6, 2020 – Botulinum toxin – best known by the brand name Botox – is a popular treatment to reduce facial lines and wrinkles. Over the years, plastic surgeons have explored alternative approaches to maximize effectiveness while minimizing side effects of botulinum toxin injection, including smaller doses and more-diluted concentrations. Now a team of…

Social distancing may have saved more than 59,000 u.s. Lives if implemented two weeks earlier

Implementing social distancing, business closures, and other non-pharmaceutical interventions (NPIs) in the U.S. two weeks sooner, during the earliest stages of the COVID-19 pandemic, may have prevented more than a million cases and saved more than 59,000 lives prior to May 3, 2020, when many state and local governments began relaxing restrictions, according to a…

Two-birds-one-stone strategy shows promise in RNA-repeat expansion diseases

JUPITER, FL–A new strategy for treating a variety of diseases known as RNA-repeat expansion disorders, which affect millions of people, has shown promise in proof-of-principle tests conducted by scientists at Scripps Research. The results suggest that someday, a handful of well-targeted drugs might be able to treat the more than 40 human disorders–including Huntington’s disease…

Universidade Lusófona partners with Bentham Science

Bentham Science is pleased to announce an Institutional Member partnership with the Portugese university, Universidade Lusófona. The partnership gives researchers from the university an opportunity to publish their research under an Open Access license under economical terms. This agreement is a continuation of Bentham Science Publishers’ vision to make transformative agreements with renowned institutions around…